Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹137 Cr.
Stock P/E
26936.5
P/B
1.6
Current Price
₹153.1
Book Value
₹ 97
Face Value
10
52W High
₹174.7
52W Low
₹ 60
Dividend Yield
0%

Fresita Proteins Overview

Business

Sarda Proteins Ltd. operates primarily in the Trading sector, specifically dealing with protein-related commodities. The company's core business involves acting as an intermediary in the supply chain, purchasing various protein products (likely agricultural commodities such as oilseeds, pulses, animal feed ingredients like soybean meal or fish meal, or other protein sources) from producers and selling them to processors, distributors, or end-users. Its business model relies on identifying market demand and supply imbalances, managing logistics, and facilitating efficient transactions. The company generates revenue primarily through the margins earned on the difference between the purchase and sale price of these protein commodities, potentially supplemented by fees for related services like warehousing or quality assurance.

Revenue Mix

Specific details regarding key business segments or revenue mix are not publicly available based on the provided information. However, given its name, it is highly probable that its operations are concentrated within various sub-categories of protein trading, which could include segments like animal feed proteins, plant-based proteins for human consumption, or industrial proteins.

Industry

The company operates in the Indian Trading industry, which, particularly for commodities, is characterized by high volume, often thin margins, and significant sensitivity to price fluctuations. It is a competitive landscape with numerous players ranging from regional traders to large national and international commodity houses. Given the limited information, Sarda Proteins Ltd. likely positions itself as a participant within the broader Indian agricultural or food commodity trading market, focusing on the protein segment. Its specific market share or competitive standing against peers cannot be determined without further data.

MOAT

Pure trading companies generally face challenges in establishing strong, durable competitive advantages. Potential moats, if any, for Sarda Proteins Ltd. could stem from:

Strong Supplier/Buyer Relationships: Established long-term trust and network with producers and consumers, ensuring reliable sourcing and off-take.

Logistical Efficiency: An optimized supply chain, including efficient warehousing, transportation, and distribution, which can reduce costs and improve delivery times.

Market Intelligence: Superior insights into real-time supply and demand dynamics, pricing trends, and regulatory changes, allowing for advantageous trading decisions.

Financial Strength & Risk Management: Ability to manage large inventories, extend credit, and effectively hedge against commodity price volatility.

Without specific details, it is difficult to ascertain the extent of any durable competitive advantage for Sarda Proteins Ltd.

Growth Drivers

Key factors that could drive Sarda Proteins Ltd.'s growth over the next 3-5 years include:

Rising Protein Consumption in India: Increasing population, disposable incomes, and dietary shifts towards higher protein intake will boost demand for protein-rich commodities.

Growth of Livestock & Aquaculture Industries: Expansion in these sectors will directly increase demand for protein-rich animal feed ingredients.

Expansion of Food Processing Sector: Higher demand for various protein ingredients from the growing Indian food processing industry.

Supply Chain Optimization and Network Expansion: Enhancing efficiency in sourcing, storage, and distribution, and expanding reach to new geographical markets or product categories.

Diversification into Value-Added Services: Offering additional services like processing, branding, or specialized logistics could open new revenue streams.

Risks

Commodity Price Volatility: Fluctuations in the prices of protein commodities can significantly impact trading margins and lead to inventory losses.

Supply Chain Disruptions: Adverse weather conditions, geopolitical events, logistical bottlenecks, or quality issues can disrupt sourcing and delivery.

Regulatory & Policy Changes: Changes in import/export policies, agricultural subsidies, food safety standards, or trade tariffs in India can affect operations and profitability.

Intense Competition: The trading sector is highly competitive, leading to potential margin compression.

Credit Risk: Risk of default by buyers or suppliers, impacting cash flow and financial stability.

Foreign Exchange Fluctuations: If involved in international trade, currency volatility can affect profitability.

Management & Ownership

Specific details on the management team's background, experience, or ownership structure are not provided. However, many companies in India with "Ltd." designation and a family-like name (e.g., "Sarda") are often promoter-led or family-owned businesses. The quality of management and specific ownership structure cannot be assessed without further information.

Outlook

Sarda Proteins Ltd. operates in a market with inherent demand tailwinds driven by India's growing population and evolving dietary preferences for protein. The company's ability to capitalize on this demand will depend on its operational efficiency, robust risk management strategies against commodity price volatility, and its ability to maintain strong relationships across its supply chain. The bull case would see the company efficiently leveraging increasing protein consumption and expanding its trading network to capture market share and improve profitability. Conversely, the bear case highlights risks from intense competition, unforeseen commodity price swings, and potential disruptions in the agricultural supply chain, which could squeeze margins and constrain growth if not effectively mitigated. Success will hinge on agile market responsiveness and disciplined financial and operational management in a dynamic trading environment.

Fresita Proteins Share Price

Live · BSE · Inception: 1991
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Fresita Proteins Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 0 0 0 24 0 11 4 0 1 13
Other Income 0 0 0 0 0 0 0 0 0 5
Total Income 0 0 0 24 0 11 4 0 1 18
Total Expenditure 0 0 0 24 0 11 4 0 0 16
Operating Profit 0 -0 0 0 -0 -0 0 -0 1 2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -0 0 0 -0 -0 0 -0 1 2
Provision for Tax -0 0 0 0 0 0 0 0 0 1
Profit After Tax 0 -0 0 0 -0 -0 0 -0 1 2
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 -0 0 0 -0 -0 0 -0 1 2
Adjusted Earnings Per Share 0.1 -0.5 0.6 0.6 -0.7 -2.9 2.3 -0.7 0.8 1.8

Fresita Proteins Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 5 2 6 6 7 5 11 11 6 1 24 18
Other Income 0 0 0 0 0 0 0 0 0 0 0 5
Total Income 5 2 6 6 7 5 11 11 6 1 24 23
Total Expenditure 5 2 6 6 7 5 11 10 6 1 24 20
Operating Profit -0 -0 -0 -0 -0 0 0 0 0 0 0 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 1 0 0 0 0 0 0 -0 0 0 0 0
Profit Before Tax 1 -0 -0 -0 -0 0 0 0 0 0 0 3
Provision for Tax 0 -0 -0 -0 0 0 0 0 0 -0 0 1
Profit After Tax 1 -0 -0 -0 -0 0 -0 0 -0 0 0 3
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 -0 -0 -0 -0 0 -0 0 -0 0 0 3
Adjusted Earnings Per Share 2.4 -0.9 -0.8 -1.9 -0.7 0.2 -0.1 1.8 -0.2 0.1 0 4.2

Fresita Proteins Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 3 3 3 2 2 2 2 2 2 2 2
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Total Current Liabilities 0 1 0 0 0 0 0 0 0 0 0
Total Liabilities 3 3 3 2 2 2 2 2 2 2 3
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 1 0 0 0 0 0 0 0 0 0
Total Current Assets 2 2 2 2 2 2 2 2 2 2 3
Total Assets 3 3 3 2 2 2 2 2 2 2 3

Fresita Proteins Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1 1 0 1 0 0 0 0 0 0
Cash Flow from Operating Activities -1 -1 -0 0 -1 -0 -0 0 -0 -0 -0
Cash Flow from Investing Activities 2 0 -0 0 0 0 0 0 0 0 0
Cash Flow from Financing Activities -0 0 -0 -0 0 -0 -0 -0 0 -0 0
Net Cash Inflow / Outflow 1 -1 -1 0 -0 0 0 0 -0 -0 -0
Closing Cash & Cash Equivalent 1 1 0 1 0 0 0 0 0 0 0

Fresita Proteins Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.43 -0.89 -0.77 -1.92 -0.72 0.19 -0.12 1.78 -0.19 0.11 0.03
CEPS(Rs) 2.6 -0.79 -0.68 -1.85 -0.66 0.21 -0.11 1.78 -0.19 0.11 0.03
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 11.24 10.86 10.09 8.18 7.46 7.65 7.53 9.32 9.13 9.24 9.27
Core EBITDA Margin(%) -2.52 -6 -2.66 -6.27 -1.44 1.81 -0.18 2.51 -2.53 -11.29 0.08
EBIT Margin(%) 12.59 -6.78 -2.88 -6.46 -1.16 3.24 0.55 3.28 0.22 1.47 0.08
Pre Tax Margin(%) 12.27 -8.14 -3.1 -6.51 -1.21 3.16 0.54 3.28 0.22 1.46 0.08
PAT Margin (%) 11.78 -7.45 -2.14 -5.85 -1.71 0.61 -0.18 2.86 -0.57 1.5 0.02
Cash Profit Margin (%) 12.62 -6.59 -1.9 -5.66 -1.59 0.67 -0.17 2.86 -0.57 1.5 0.02
ROA(%) 23.13 -5.2 -4.7 -15.07 -6.74 1.81 -1.08 14.72 -1.45 0.85 0.21
ROE(%) 24.23 -6.67 -7.31 -20.98 -9.15 2.52 -1.55 21.15 -2.08 1.23 0.32
ROCE(%) 23.35 -4.5 -5.96 -14.89 -3.92 8.38 3 15.81 0.55 0.8 0.86
Receivable days 9.24 0 39.17 43.75 35.7 52.53 25.78 16.59 0 0 0
Inventory Days 37.03 178.8 77.88 47.65 0 0 0 0 0 0 0
Payable days 1.19 1.01 0.23 0.23 0.03 0 0 0 0 0 3.42
PER(x) 0 0 0 0 0 0 0 20.94 0 478.13 4228.81
Price/Book(x) 0 0 0 0.58 0 0 1.39 4 6.33 5.82 13.46
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.31 1.01 0.27 0.05 0.23 0.3 0.15 0.57 1.69 7.07 0.89
EV/Core EBITDA(x) -14 -17.14 -10.3 -0.78 -22.32 9.11 26.45 17.17 755.15 482.51 1048.62
Net Sales Growth(%) 103.6 -58.93 199.69 -8.54 27.7 -25.17 110.35 -5.28 -46.14 -77.64 1766.88
EBIT Growth(%) 494 -122.11 -27.53 -104.97 77.14 309.49 -64.15 463 -96.33 46.59 7.93
PAT Growth(%) 586.88 -125.98 14.04 -150.46 62.68 126.66 -161.6 1616.4 -110.74 158.79 -73.74
EPS Growth(%) 586.84 -136.65 14.04 -150.46 62.68 126.66 -161.62 1616.34 -110.74 158.78 -73.78
Debt/Equity(x) 0.08 0.23 0.08 0 0 0 0 0 0 0 0
Current Ratio(x) 7.17 3.28 7.41 42.59 60.82 43.87 57.33 62.92 98.07 124.65 10.51
Quick Ratio(x) 5.83 1.12 4.16 32.19 60.82 43.87 57.33 62.92 98.07 124.65 10.51
Interest Cover(x) 39.79 -4.98 -13.48 -127.32 -21.46 39.27 43.31 1774.16 498.35 160.97 68.33
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +2300% +30% +37% +17%
Operating Profit CAGR — — — —
PAT CAGR — — — -100%
Share Price CAGR +52% +54% +33% +42%
ROE Average 0% 0% +4% 0%
ROCE Average +1% +1% +4% +2%

Fresita Proteins Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 80.47 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 19.53 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 0000000080.6680.47
FII 0000000000
DII 0000000000
Public 10010010010010010010010019.3419.53
Others 0000000000
Total 100100100100100100100100100100

Fresita Proteins Peer Comparison

Fresita Proteins Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Fresita Proteins Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of -0% over the last 3 years.
  • Debtor days have increased from 0 to 3.42days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp